Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced the appointment of Dr. William ...

Seven Bridges Specialty, a specialty pharmacy services innovator, is proud to announce the appointment of Steve Granzyk as President and Chief Executive Officer. Steve brings over three decades of ...

According to research, about 3% of the population experience hyperphantasia, and they often say that seeing in their mind’s ...

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products ...

Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the ...

Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise ...

Kyverna Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Naji Gehchan, M.D., MBA, as Chief ...

INDONESIA needs 29,000 more specialist doctors to meet its current healthcare needs, while the country’s collective educational institutions can produce only 2,700 new specialists per year. Read more ...

Incorporating visual arts into neurology training develops residents’ observational skills, fosters empathy and humanity, and encourages personal growth.

The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the ...

Part artist and part engineer, the conceptual artist and musician Beatie Wolfe is inviting visitors into her head.

An article in the medical journal Neurology lists specific questions people should ask their neurologist or primary care ...